Halozyme Therapeutics (HALO) Total Non-Current Liabilities (2010 - 2026)
Halozyme Therapeutics (HALO) posted Total Non-Current Liabilities of $2.33 billion for Q2 2026, up 41.9% from $1.64 billion a year earlier but down 0.7% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Total Non-Current Liabilities came in at $2.36 billion, up 43.6% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 40.9% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Total Non-Current Liabilities was $1.64 billion in FY2024 (+2.1%), $1.61 billion in FY2023 (-1.7%), $1.64 billion in FY2022 (+80.7%) and $906.93 million in FY2021 (+113.2%).
- Quarterly Total Non-Current Liabilities has run from a low of $901.82 million in Q1 2022 to a high of $2.36 billion in Q4 2025 over five years.
- On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last four quarters, with growth averaging 16.5% over the last eight quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2021, with growth of 114.2%; the weakest was Q4 2023, with a decline of 1.7%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $2.35 billion (Q1 2026), $2.36 billion (Q4 2025) and $1.65 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 2.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Bn |
| Mar 31, 2026 | 2.35 Bn |
| Dec 31, 2025 | 2.36 Bn |
| Sep 30, 2025 | 1.65 Bn |
| Jun 30, 2025 | 1.64 Bn |
| Mar 31, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.64 Bn |
| Sep 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 1.63 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 1.62 Bn |
| Jun 30, 2023 | 1.63 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 1.64 Bn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 1.36 Bn |
| Mar 31, 2022 | 901.82 Mn |
| Dec 31, 2021 | 906.93 Mn |
| Sep 30, 2021 | 902.14 Mn |
API Access
Halozyme Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();